IL2 and neoplasm: Furthermore, the tumor-bearing animals in our study treated with E7 DNA vaccines in combination with both IL-2 and IL-15 cDNAs displayed significantly lower therapeutic antitumor activity compared to animals treated with E7 DNA vaccines alone (data not shown), suggesting potential opposing roles of IL-2 and IL-15 in activating T cell responses.